Trump Touts Medicaid Drug Savings, But Details Remain Murky

President Trump and top health officials say pharmaceutical deals using 'most favored nation' pricing will save Medicaid tens of billions over a decade, with Trump floating figures as high as $100 billion and claiming the plan will 'save Medicaid' outright.

But the agreements themselves are largely confidential, and experts say nobody outside the administration knows which drugs are covered, how many states will participate, or how long the deals last. CMS says the program covers 'hundreds' of drugs, which sounds impressive until you remember Medicaid already negotiates steep discounts and the White House's own projections put state savings at under 2% of annual Medicaid drug spending, shrinking over time.

Policy researchers describe a 'cone of silence' around the actual terms, while RFK Jr. and Dr. Oz layer on talk of rescued state budgets and crowded-out schools and roads. The one number everyone agrees on is that nobody outside the administration can verify the big one.

The full dispatch is available from the source below.